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Objective: To examine the relation between sleep duration and metabolic syndrome (MetS).
Methods: We examined the baseline data from 4356 healthy workers (3556 men and 800 
women) aged 19–69 years. The physical activity of each participant was classified   according 
to the International Physical Activity Questionnaire (IPAQ). We defined four components 
of MetS diagnostic components in this study as follows: 1) high blood pressure (BP) 
systolic BP [SBP] $ 130 mmHg, or diastolic BP [DBP] $ 85 mmHg, or on medication; 
2)   dyslipidemia (high-density lipoprotein-cholesterol concentration ,40 mg/dL, or triglycerides 
concentration $150 mg/dL, or on medication; 3) impaired glucose tolerance (fasting blood sugar 
concentration $ 110 mg/dL, or if less than 8 hours after meals $ 140 mg/dL), or on medication; 
and 4) overweight (body mass index [BMI] $ 25 kg/m2), or obesity (BMI $ 30 kg/m2). There 
were 680 participants in the group, with sleep duration ,6 hours (15.6%).
Results: Those who had 0–4 MetS diagnostic components, including overweight, accounted 
for 2159, 1222, 674, 255, and 46 participants, respectively, in the Poisson distribution. Poisson 
regression analysis revealed that independent factors that contributed to the number of MetS 
diagnostic components were being male (regression coefficient b = 0.752, P , 0.001), age 
(b = 0.026, P , 0.001), IPAQ classification (b = −0.238, P = 0.034), and alcohol intake (mL/day) 
(b = 0.018, P , 0.001). Short sleep duration (,6 hours) was also related to the number of 
MetS (b = 0.162, P , 0.001). The results of analyses with obesity component showed a similar 
association.
Conclusion: Short sleep duration was positively associated with the number of MetS diagnostic 
components independent of other lifestyle habits.
Keywords: short sleep duration, MetS diagnostic components, obesity
Introduction
The components of metabolic syndrome (MetS) diagnostic criteria, including high 
blood pressure (BP), dyslipidemia, impaired glucose tolerance (IGT), and   obesity are 
thought to be related to daily lifestyle habits, including alcohol drinking,   smoking, and 
physical activity.1–4 It has also been reported that both a decrease and an increase in 
sleep duration were associated with an increase in cardiovascular and   noncardiovascular 
mortality.5,6 U-shaped associations were observed between sleep (,5, 5, 6, 7, $8 hours) 
and MetS.7
Numerous studies have shown that separate components of MetS are associated with 
a higher risk of coronary heart disease and stroke, and that a rise in the number of MetS 
components increases the incidence of cardiovascular disease (CVD) events following 
myocardial infarction.8–10 Thus, preventing development of each component of MetS Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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using diagnostic criteria is more important than   dichotomizing 
people into two groups, with and without MetS.
In the present study we comprehensively examined cross-
sectionally the relation between sleep duration and other 
lifestyle habits including physical activity, smoking, alcohol 
intake, and the number of MetS diagnostic components in a 
large sample of healthy workers in Japan.
Methods
Participants
We analyzed baseline data from the High-Risk and Population 
Strategy for Occupational Health Promotion (HIPOP-OHP) 
Study.11–14 In brief, HIPOP-OHP was an interventional survey 
to establish a methodology for reducing CVD risk factors at 
the workplace. This study population consisted of full-time 
workers at 12 large-scale companies throughout Japan. Each 
company had 500–1000 employees. Researchers followed 
data on CVD risk factors, lifestyle habits and consciousness 
about health, based on nutrition, physical activity, and smok-
ing for 4 years.11–14 This study was performed as part of the 
management of safety and health with the approval of the 
Safety Hygiene Committee at each company. Accordingly, 
all employees were enrolled in this study. However, participa-
tion was voluntary, and we explained there was no need for 
participants to answer the required questionnaire if they did 
not want to. Approval for the study was obtained from the 
Institutional Review Board of Shiga University of Medical 
Science for ethical issues (No. 10–16). From 1999–2000, 
baseline data were collected from 7346 male and female 
workers aged from 19 to 69 years old.
The present study examined baseline data from 4356 
participants (3556 men and 800 women) ages 19–69 years 
(mean ± standard deviation: 41.3 ± 9.6 years) who underwent 
physical examination, a lifestyle survey, and blood chemical 
examination.
Data collection and standardization
Physical and laboratory data were standardized according to 
the manual of the HIPOP-OHP research group.11 Briefly, after 
5 minutes of silent rest measured by a sandglass, blood pressure 
was measured twice for each participant using an automatic 
sphygmomanometer (Nihon Colin, BP-103iII) at each com-
pany, and the mean value was recorded. To measure the lipid 
concentrations in each participant, the company established a 
contract with a clinical laboratory; the blood testing was stan-
dardized through the US Cholesterol Reference Method Labo-
ratory Network (CRMLN).15 The body mass index (BMI) was 
calculated as weight (kg) divided by height squared (m2).
Participants were asked about the type of, and time 
spent on, physical activities in their spare time for recreation, 
exercise, or sport in the previous month. The physical activity 
of each participant was converted into metabolic equivalent 
task (MET)-minutes per week (=MET level × minutes of 
activity/day × days per week) according to IPAQ,16 and par-
ticipants were classified into four classes of physical activity 
as: class 1, sedentary (,600 MET-minutes per week); class 2, 
some activity (,1500 but $600 MET-minutes per week); 
class 3, moderate activity (,3000 but $1500   MET-minutes 
per week); or class 4, high ($3000 MET-minutes per week). 
Drinking habits for each subject were assessed by a question-
naire common to all companies.12 The frequency of alcohol 
intake during a typical week and the total alcohol intake 
on each occasion were determined and used to calculate 
the alcohol intake per week. This value was then divided 
by 7 to obtain the average alcohol intake per day. Subjects 
were asked to estimate their alcohol intake based on gou, 
a traditional Japanese drinking unit corresponding to 23 g of 
ethanol. One gou is equivalent to 2 US and UK drink units, 
or 180 mL of sake, and its ethanol content is roughly equiva-
lent to that of a bottle of beer (663 mL), two single shots of 
whiskey (70 mL), a half glass of shochu (110 mL), or 240 mL 
of wine. Drinkers were defined as those consuming more than 
0.3 gou (0.6 drinks) per week (1 g of ethanol a day).
Sleep duration was investigated by the question, “How 
many hours of sleep do you get on an average weekday per 
night?” in the lifestyle survey. Sleep duration of participants 
was categorized in four groups: ,6 hours, 6 to ,7 hours, 
7 to ,8 hours, and $8 hours, with reference to a precedent 
study.7
We defined four components for MetS in this study 
according to previous studies3,17,18 as follows: 1) high BP, 
SBP $ 130 mmHg, or DBP $ 85 mmHg, or the use of an anti-
hypertensive drug; 2) dyslipidemia, either serum high-density 
lipoprotein (HDL) cholesterol concentration ,40 mg/dL, 
or serum triglycerides (TG) concentration $150 mg/dL, 
or on medication for dyslipidemia; 3) IGT, fasting blood 
glucose concentration $ 110 mg/dL, or if less than 8 hours 
after meals $140 mg/dL), or on medication for diabetes 
mellitus; and 4) overweight, BMI $ 25 kg/m2, or obesity, 
BMI $ 30 kg/m2.
Statistical analyses
The chi-square statistical test for nominal variables and 
one way analysis of variance for continuous variables 
were performed to assess whether there were significant 
differences among the groups stratified by sleep duration. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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Associations between the number of MetS diagnostic 
components, including   overweight component, and sleep 
duration categories, taking a sleep duration of 6–7 hours as 
a reference, were analyzed by Poisson regression   models. 
Model 1 included sex and age as covariates. Model 2 
included model 1 covariates + IPAQ   classification,   smoking 
(non-, past, or current smoker; nonsmoker serves as reference), 
alcohol intake (mL/day), and interaction terms (IPAQ × male, 
alcohol intake × male, current   smoking × male). The above 
analyses were repeated after overweight component was 
replaced by obesity component. The associations between 
high BP, dyslipidemia, IGT, overweight, obesity, and sleep 
duration categories were analyzed by logistic regression mod-
els, adjusted for sex, age, IPAQ classification,   smoking (non-, 
past, or current smoker;   nonsmoker serves as   reference), 
alcohol intake, and interaction terms (IPAQ × male, alcohol 
intake × male, current smoking × male) as covariates. All 
P values were two-sided, and P , 0.05 was considered 
significant. All analyses were performed using SPSS v15 
(Chicago, IL, USA).
Results
Among  the  4356  participants  (3556 men  and  800 
women), 680 (15.6%) were in the group of sleep dura-
tion ,6 hours, 1779 in the group of sleep duration 
6 to ,7 hours (40.8%), 1488 in the group of sleep 
duration 7 to ,8 hours (34.2%), and 409 in the group of 
sleep duration .8 hours (9.4%). There were 974 overweight 
(BMI $ 25 kg/m2) participants (22.4%), and 116 participants 
(2.7%) with obesity (BMI $ 30 kg/m2). Those who had 0–4 
MetS diagnostic components, including overweight compo-
nent, accounted for 2159, 1222, 674, 255, and 46 persons, 
respectively, in the Poisson distribution. Characteristics 
of participants by group according to sleep duration are 
shown in Table 1. The mean SBP, DBP, alcohol intake, 
and percentage of current smokers were higher among the 
groups with a longer sleep duration. The mean BMI and 
percentage of obesity were lower among the groups with a 
longer sleep duration.
The results of Poisson regression analysis are shown 
in Table 2. The shortest sleep duration category contrib-
uted significantly to the number of MetS components 
in both models. Independent factors that contributed to 
the number of MetS diagnostic components were being 
male (regression coefficient b = 0.639, P , 0.001), age 
(b = 0.026, P , 0.001), ,6 hours of sleep duration 
(b = 0.141, P , 0.001) in model 1. In model 2, factors sig-
nificantly contributing to the number of MetS components 
were being male (b = 0.752, P , 0.001), age (b = 0.026, 
P , 0.001), IPAQ classification (b = –0.238, P = 0.034), alco-
hol intake (mL/day) (b = 0.018, P , 0.001), and ,6 hours 
of sleep duration (b = 0.162, P , 0.001). The interaction 
term (alcohol intake × male) contributed significantly to the 
number of MetS components (b = −0.017, P , 0.001). The 
contribution of current smoking (b = −0.115, P = 0.559) 
was not statistically significant. Although there were very 
few participants with obesity, the analyses repeated after 
overweight component was replaced by obesity component 
showed a similar association between short sleep duration 
and the number of MetS components.
The results of logistic regression analysis on associations 
between individual components of MetS and sleep duration 
adjusted for other lifestyle habits are shown in Table 3. For 
high BP, being male (odds ratio [OR] = 2.68, 95% confi-
dence intervals = [1.58–4.52] P , 0.001), age (OR = 1.05 
[1.04–1.06], P , 0.001), and IPAQ (OR = 0.65 [0.42–0.99], 
P = 0.044) contributed significantly. Sleep duration catego-
ries did not contribute to high BP. For dyslipidemia, being 
male (OR = 3.70 [2.02–6.74], P , 0.001), age (OR = 1.03 
[1.02–1.03], P , 0.001), sleep ,6 hours (OR = 1.27 
[1.03–1.56], P = 0.023), and IPAQ (OR = 0.60 [0.37–0.98], 
P = 0.040) contributed significantly. For IGT, age (OR = 1.09 
[1.08–1.12], P , 0.001), ,6 hours sleep (OR = 1.49 
[1.03–2.15], P = 0.037) contributed significantly. For over-
weight, being male (OR = 1.72 [1.01–2.95], P , 0.001), 
age (OR = 1.02 [1.01–1.02], P = 0.048), ,6 hours sleep 
(OR = 1.31 [1.06–1.61], P = 0.011), and 7 to ,8 hours of 
sleep duration (OR = 0.79 [0.66–0.94], P = 0.010) contributed 
significantly. For obesity, age (OR = 0.95 [0.93–0.97], 
P , 0.001), and ,6 hours sleep (OR = 1.90 [1.18–3.05], 
P = 0.008) contributed significantly. Thus, for 3 out of 4 
MetS diagnostic components, ,6 hours sleep contributed 
positively. For overweight, 7 to ,8 hours of sleep duration 
inversely contributed significantly.
Discussion
In the present study, we found a significant positive asso-
ciation between short sleep duration (,6 hours compared 
with 6–7 hours sleep duration) and the number of MetS 
diagnostic components, regardless of BMI cutoff point was 
taken either $25 kg/m2, or $30 kg/m2. Most previous stud-
ies showed an association between short sleep   duration and 
the risk of MetS, and some studies also showed that a longer 
sleep duration was associated with the risk of MetS. Santos 
et al studied 2164 Portuguese men and women, and found 
an association between a decrease in physical   activity, an Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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Table 1 characteristics of participants by group according to sleep duration – hiPOP-OhP study
Sleep durationa
,6 hours 6 to ,7 hours 7 to ,8 hours .8 hours Total P value
Person n 680 1779 1488 409 4356
Age (years) 40.4 ± 9.5 41.4 ± 9.4 41.4 ± 9.6 42.4 ± 10.0 41.3 ± 9.6 0.010
Female (%) 22.1 21.8 14.7 10.8 18.4 ,0.001
SBP (mmhg) 117 ± 17 117 ± 17 119 ± 17 121 ± 16 118 ± 17 0.003
DBP (mmhg) 72 ± 12 72 ± 12 73 ± 12 75 ± 12 73 ± 12 ,0.001
high BP (%) 24.3 24.1 25.8 28.4 25.1 0.275
Dyslipidemia (%) 29.6 25.9 26.3 28.4 26.8 0.251
igT (%) 7.5 6.0 6.3 7.3 6.5 0.501
BMi (kg/m2) 23.3 ± 3.5 23.0 ± 3.2 22.8 ± 3.0 22.8 ± 3.0 23.0 ± 3.2 0.004
BMi $ 25 kg/m2 (%) 27.2 23.1 19.5 21.8 22.4 ,0.001
BMi $ 30 kg/m2 (%) 4.7 2.5 2.3 1.5 2.7 0.003
iPAQ 1.3 ± 0.6 1.3 ± 0.6 1.4 ± 0.7 1.3 ± 0.7 1.3 ± 0.6 0.005
current smoking (%) 42.9 44.9 47.8 57.5 46.7 ,0.001
Alcohol intake (mL/day) 17.9 ± 32.6 17.6 ± 27.9 20.9 ± 29.7 27.7 ± 39.9 19.7 ± 30.7 ,0.001
MetS no Ab 0.88 ± 0.99 0.79 ± 0.97 0.78 ± 0.95 0.86 ± 1.00 0.81 ± 0.97 0.064
MetS no Bc 0.66 ± 0.82 0.58 ± 0.79 0.61 ± 0.78 0.66 ± 0.82 0.61 ± 0.79 0.116
Notes: The chi-square statistical test for nominal variables and one way analysis of variance for continuous variables were performed to assess whether there were 
significant differences among the groups stratified by sleep duration. We defined four components for MetS in this study as follows: 1) High BP, SBP $ 130 mmhg, 
or DBP $ 85 mmhg, or the use of an antihypertensive drug; 2) dyslipidemia, hDL , 40 mg/dL, or Tg $ 150 mg/dL, or on medication for dyslipidemia; 3) igT, fasting 
blood sugar concentration $ 110 mg/dL, or if less than 8 hours after meals $ 140 mg/dL), or on medication for diabetes mellitus; 4) overweight, defined as BMI $ 25 kg/m2, 
or obesity, defined as BMI $ 30 kg/m2. aSleep duration = average sleeping hours per night on weekdays. bMetS no A = number of MetS component including overweight 
component. cMetS no B = number of MetS component including obesity component.
Abbreviations: BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; igT, impaired glucose tolerance; BMi, body mass index; iPAQ, international 
Physical Activity Questionnaire classification; MetS, metabolic syndrome; HDL, high-density lipoprotein; TG, triglycerides; IGT, impaired glucose tolerance.
Table 2 independent factors that contributed to the number of metabolic syndrome diagnostic components and sleep duration and 
lifestyle habits – results of Poisson regression analysis
Variable Overweight  Obesity
Model 1a Model 2b Model 1a Model 2b
βc P value βc P value βc P value βc P value
Male gender 0.639 ,0.001 0.752 ,0.001 0.670 ,0.001 −0.154 0.805
Age (year) 0.026 ,0.001 0.026 ,0.001 0.028 ,0.001 −0.049 ,0.001
Sleep group ,6 hours (680) 0.141 ,0.001 0.162 ,0.001 0.152 0.007 0.641 0.008
6 to ,7 hours (1779) ref ref ref ref
7 to ,8 hours (1488) −0.057 0.152 −0.045 0.270 −0.007 0.878 −0.032 0.893
$8 hours (409) −0.006 0.920 −0.050 0.435 0.020 0.769 −0.328 0.460
iPAQ −0.238 0.034 −0.351 0.547
current smoking −0.115 0.559 −0.588 0.459
Alcohol intake (mL/day) 0.018 ,0.001 0.041 0.307
iPAQ × male 0.176 0.078 0.119 0.804
Alcohol intake × male −0.017 ,0.001 −0.045 0.258
Smoking × male  0.158 0.382  0.271 0.689
Notes: results of analysis by Poisson regression models on associations between the number of MetS diagnostic components (including overweight or obesity component) 
and lifestyle are shown. aModel 1, adjusted for sex and age. bModel 2, adjusted for the variables in model 1 plus iPAQ, current smoking, alcohol intake, and interaction terms 
(iPAQ × male, alcohol intake × male, current smoking × male). cβ = regression coefficient.
Abbreviations: IPAQ, International Physical Activity Questionnaire classification; MetS, metabolic syndrome.
increase in sleeping hours, and the risk of MetS.19 Hall et al 
studied   self-reported sleep duration associated with MetS 
in a cross-sectional   community-based cohort and found 
that both short (,7 hours per night) and long ($8 hours 
per night) sleep duration were significantly correlated with 
MetS in middle-aged adults.7 On the other hand, in a study 
by Choi et al with 4222 Korean participants, short and long 
sleep duration were related to increased risk of MetS, while 
subjects with sleep duration of 7 hours demonstrated the 
lowest prevalence of MetS.20
Because obesity results in development of MetS diagnos-
tic components, the most likely reason for the association Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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between short sleep duration and MetS may come from 
the association between short sleep duration and obesity. 
We also found significant positive associations between 
sleep duration ,6 hours and obesity. Furthermore, sleep 
duration 7–8 hours was associated with the lowest risk 
of obesity in our study. Previous studies indicated a clear 
association between short sleep duration and elevated BMI 
and obesity,21–23 reduced leptin, and elevated ghrelin.24,25 One 
mechanism by which short duration sleep may predispose 
to weight gain is by increasing caloric intake. Partial sleep 
deprivation experiments in humans caused hyperphagia. 
Comparing 4 hours of sleep per night to 10 hours over 
a period of 2 days, both hunger and appetite scores on a 
visual analog scale were elevated by sleep deprivation.25 
In a   situation where food is readily available, sleep depriva-
tion may simply represent an increased opportunity to eat, 
especially if most of the waking-time is spent in sedentary 
activities such as watching television.26 In the epidemiologic 
literature, those studies that attempted to quantify caloric 
intake found no relationship between sleep duration and 
dietary consumption.27–30 However, two epidemiologic stud-
ies demonstrated that short sleepers have reduced levels of 
leptin and elevated levels of ghrelin, supporting an effect 
of short sleep durations on appetite regulation.24,31 Chronic 
partial sleep deprivation also clearly leads to feelings of 
fatigue, and this tiredness may lead to reductions in physi-
cal activity. In the Nurses’ Health Study and Nurses’ Health 
Study 2, short sleep durations were associated with reduced 
reported physical activity.27,32
In the present study, short sleep duration was associ-
ated with the risk of IGT. Previous cross-sectional studies 
indicated that short and long sleep duration were associated 
with an increased risk of developing IGT or diabetes mellitus, 
independent of confounding factors.33–35
We also found an association between dyslipidemia and 
shorter sleep duration, and several studies have shown this 
association. In a study by van den Berg et al, people who slept 
longer and spent more time in bed had a higher total/HDL 
cholesterol ratio among 768 participants of the   Rotterdam 
Study.36 In another study by Kaneita et al, both short and 
long sleep duration were associated with a high serum TG 
level or a low HDL cholesterol level, whereas compared 
with men sleeping 6–7 hours, the risk of a high low-density 
lipoprotein (LDL) cholesterol level was lower among men 
with sleeping duration $8 hours.37
We found no association between high BP and sleep dura-
tion. Additional analysis between short duration sleep and 
hypertension (defined as SBP $ 140, or DBP $ 90 mmHg, or 
on anti-hypertensive medication) yielded similar results (data 
not shown). However, several studies showed an association 
between short sleep duration and hypertension. In a study in 
a cohort of 10,308 British civil servants aged 35–55 years, 
short sleep duration (#5 hours per night) was associated with 
a higher risk of hypertension compared with a group sleeping 
Table 3 independent factors that contributed to high BP, dyslipidemia, igT, overweight, obesity and sleep duration including other 
lifestyle habits – results of logistic regression analysis
Variable High BP 
(N = 1094)
Dyslipidemia 
(N = 1169)
IGT 
(N = 282)
Overweight 
(N = 974)
Obesity 
(N = 116)
OR 95% CI OR  95% CI OR 95% CI OR  95% CI OR 95% CI
Male gender 2.68a 1.58–4.52 3.70a 2.02–6.74 1.96 0.39–9.77 1.72a 1.01–2.95 0.86 0.25–2.92
Age 1.05a 1.04–1.06 1.03a 1.02–1.03 1.09a 1.08–1.12 1.02b 1.01–1.02 0.95a 0.93–0.97
Sleep ,6 hours 
(594)
1.09 0.88–1.36 1.27b 1.03–1.56 1.49b 1.03–2.15 1.31b 1.06–1.61 1.90a 1.18–3.05
6 to ,7 hours 
(1557)
ref ref ref ref ref
7 to ,8 hours 
(1297)
1.06 0.90–1.26 0.96 0.82–1.14 1.01 0.74–1.37 0.79b 0.66–0.94 0.97 0.61–1.54
$8 hours (344) 1.01 0.76–1.31 0.97 0.75–1.25 0.95 0.59–1.50 0.83 0.63–1.09 0.72 0.30–1.72
iPAQ 0.65b 0.42–0.99 0.60b 0.37–0.98 1.76 0.45–6.91 0.89 0.58–1.37 0.70 0.23–2.21
current smoking 0.64 0.30–1.39 1.22 0.54–2.73 1.02 0.12–8.95 0.82 0.39–1.72 0.56 0.12–2.63
Alcohol intake 1.02 0.99–1.04 1.02 0.99–1.05 1.04 0.95–1.14 1.03 1.00–1.05 1.04 0.96–1.13
iPAQ × male 1.41 0.98–2.03 1.34 0.86–2.05 0.60 0.16–2.25 1.14 0.78–1.67 1.12 0.44–2.87
Alcohol × male 0.99 0.97–1.01 0.98 0.95–1.01 0.96 0.88–1.05 0.97b 0.95–0.99 0.96 0.88–1.03
Smoking × male 1.35 0.67–2.70 1.06  0.50–2.22 0.98 0.12–7.92 1.29 0.67–2.51 1.31 0.35–4.93
Notes: Ors and 95% cis of analyses by logistic regression models on associations between high BP, dyslipidemia, igT, overweight (BMi $ 25 kg/m2), obesity (BMi $ 30 kg/m2) 
and sleep duration including other lifestyle habits and interaction terms (iPAQ × male, alcohol intake × male, current smoking × male) are shown. All covariates included are 
shown in this Table. aP , 0.01 bP , 0.05.
Abbreviations: OR, odds ratio; CI, confidence interval; BP, blood pressure; IGT, impaired glucose tolerance; BMI, body mass index; IPAQ, International Physical Activity 
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7 hours among women (but no association detected in men).38 
Gangwisch et al studied 4810 participants, and found that 
sleep duration of #5 hours per night was associated with a 
significantly increased risk of hypertension.39 We have no 
possible explanations for the lack of association between 
high BP and short sleep   duration in our study.
The strengths of our study include being population-
based, large-scale, and multi-site, with highly standardized 
methods. Since the study included men and women of a 
broad range of ages, the findings are likely to be generaliz-
able to middle-aged Japanese. However, our study has some 
limitations. First, this study was limited by its cross-sectional 
design. Thus, the causal implications of short sleep duration 
for MetS should be taken cautiously. Second, we did not 
measure waist circumference (WC). However, we showed in 
a population-based study that BMI and WC correlated very 
well in men and women, and that BMI could be used instead 
of WC in a study when the latter was not available.40 Third, 
although we did not have data on food intake and sleep apnea, 
these may make important contributions to MetS.
In conclusion, our results indicated that shorter sleep 
duration (,6 hours of sleep duration per night) was associ-
ated with an increased number of MetS diagnostic compo-
nents, and 7 to ,8 hours of sleep duration was associated 
with the lowest risk of obesity.
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